Yichang Humanwell Company Profile
✉ Email this page to a colleague
What is the competitive landscape for YICHANG HUMANWELL
YICHANG HUMANWELL has twenty-four approved drugs.
Summary for Yichang Humanwell
| US Patents: | 0 |
| Tradenames: | 19 |
| Ingredients: | 19 |
| NDAs: | 24 |
Drugs and US Patents for Yichang Humanwell
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yichang Humanwell | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 211052-001 | Sep 24, 2018 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yichang Humanwell | VENLAFAXINE HYDROCHLORIDE | venlafaxine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 214654-003 | Aug 6, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yichang Humanwell | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 211100-003 | Apr 2, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yichang Humanwell | FLECAINIDE ACETATE | flecainide acetate | TABLET;ORAL | 215599-001 | Sep 8, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yichang Humanwell | RIVASTIGMINE | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 215445-002 | Sep 23, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
